These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 31504079)

  • 1. The Screening Utility and Ecological Validity of the Neuropsychological Assessment Battery Bill Payment Subtest in Older Adults with and without Dementia.
    Kenney LE; Margolis SA; Davis JD; Tremont G
    Arch Clin Neuropsychol; 2019 Oct; 34(7):1156-1164. PubMed ID: 31504079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Utility and Ecological Validity of the Medication Management Ability Assessment in Older Adults with and without Dementia.
    Margolis SA; Hallowell ES; Davis JD; Kenney LE; Tremont GN
    Arch Clin Neuropsychol; 2021 Jan; 36(1):37-50. PubMed ID: 32808040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI.
    Russo MJ; Cohen G; Chrem Mendez P; Campos J; Martín ME; Clarens MF; Tapajoz F; Harris P; Sevlever G; Allegri RF
    Aging Clin Exp Res; 2018 Oct; 30(10):1167-1176. PubMed ID: 29380265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired financial abilities in mild cognitive impairment: a direct assessment approach.
    Griffith HR; Belue K; Sicola A; Krzywanski S; Zamrini E; Harrell L; Marson DC
    Neurology; 2003 Feb; 60(3):449-57. PubMed ID: 12578926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.
    Feng X; Zhou A; Liu Z; Li F; Wei C; Zhang G; Jia J
    J Alzheimers Dis; 2018; 61(4):1611-1618. PubMed ID: 29376851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.
    Li F; Jia XF; Jia J
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):227-32. PubMed ID: 23172761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Functional Cognition and Complex Everyday Activities in Older Adults with Mild Cognitive Impairment and Mild Dementia: Validity of the Large Allen's Cognitive Level Screen.
    Wesson J; Clemson L; Crawford JD; Kochan NA; Brodaty H; Reppermund S
    Am J Geriatr Psychiatry; 2017 May; 25(5):471-482. PubMed ID: 28238815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
    Tsatali M; Fotiadou F; Giaglis G; Tsolaki M
    Aging Clin Exp Res; 2019 Sep; 31(9):1305-1312. PubMed ID: 30471005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Montreal Cognitive Assessment After Omission of Hearing-Dependent Subtests: Psychometrics and Clinical Recommendations.
    Al-Yawer F; Pichora-Fuller MK; Phillips NA
    J Am Geriatr Soc; 2019 Aug; 67(8):1689-1694. PubMed ID: 31018015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informant questionnaire on cognitive decline in the elderly (IQCODE) for classifying cognitive dysfunction as cognitively normal, mild cognitive impairment, and dementia.
    Park MH
    Int Psychogeriatr; 2017 Sep; 29(9):1461-1467. PubMed ID: 28560943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.
    Van Mierlo LD; Wouters H; Sikkes SA; Van der Flier WM; Prins ND; Bremer JA; Koene T; Van Hout HP
    J Alzheimers Dis; 2017; 56(1):249-259. PubMed ID: 27911296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals.
    North C; Heatley MH; Utoomprurkporn N; Bamiou DE; Costafreda SG; Stott J
    Eur J Neurol; 2021 Jun; 28(6):1820-1828. PubMed ID: 33486875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.